The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: Clinical data of 6 months follow-up

Clinical Rheumatology

Volumn 25, Issue 3, 2006, Pages 389-393

  Migliore, Alberto ^a   Tormenta, Sandro ^a   Martin Martin, Luis Severino ^a,b   Iannessi, Francesca ^a   Massafra, Umberto ^a   Carloni, Emilia ^a   Monno, Danilo ^a,c   Alimonti, Andrea ^a   Granata, Mauro ^a,d  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b REGINA APOSTOLORUM HOSPITAL   (Italy)

^c SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^d SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Hip osteoarthritis; Hylan G F 20; Ultrasound guidance

Indexed keywords

HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ECHOGRAPHY; FEMALE; FOLLOW UP; HIP; HIP OSTEOARTHRITIS; HUMAN; INJECTION SITE REACTION; JOINT FUNCTION; MALE; MEDICAL INFORMATION; PRIORITY JOURNAL; SEPSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VISUAL ANALOG SCALE;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PAIN; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33645776955     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0052-x     Document Type: Article

References (23)

1. Balazs EA, Denlinger JL (2003) Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol 20(39):2-9
2. Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ (2000) Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43:1905-1915
3. Espallargues M, Pons JM (2003) Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: A systematic review. Int J Technol Assess Health Care 19(1):41-56
4. Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N (2002) A prospective, randomized, pragmatic health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthritis Cartilage 10:506-517
5. Adams ME, Atkinson MH, Lussier A, Schulz JI, Siminovitch KA, Wade JP et al (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F alone, hylan G-F 20 with nonsteroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3:213-226
6. Tamir E, Robinson D, Koren R, Agar G (2001) Intra-articular hyaluronan for the treatment of osteoarthritis of the knee: A randomised, double blind, placebo controlled study. Clin Exp Rheumatol 19:265-270
7. Kolarz G, Kotz R, Hochmayer I (2003) Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 32(5):310-319
8. Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F 20: A 26 week controlled trial of efficacy and safety in the osteoarthritis knee. Clin Ther 20:410-423
9. Dickson DJ, Hosie G, English JR et al (2001) A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 4:41-52
10. Brocq O, Tran G, Breuil U, Grisot C, Flory P, Euller-Zuegler L (2002) Hip osteoarthritis: Short term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69(4):388-391
11. Migliore A, Martin Martin LS, Alimonti A et al (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11:305-306
12. Migliore A, Martin Martin LS, Valente C, Alimonti A, Bernardini A, Monno D, Tormenta S (2002) Intra-articular treatment with Hylan G-F 20 (Synvisc) reduces NSAIDS consumption in patients with symptomatic osteoarthritis of the hip: Preliminary clinical observations. Osteoporosis Int 13(3):S20
13. Conrozier T, Bertin P, Mathieu P, Charlot J, Bailleul F, Treves R, Vignon E, Chevalier X (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: An open label, multicentre, pilot study. Clin Exp Rheumatol 21 605-610
14. Leopold SS, Battista V, Oliverio JA (2001) Safety and efficacy of intraarticular hip injection using anatomic landmarks. Clin Orthop Relat Res Oct(391):192-197
15. Jackson DW, Evans NA, Thomas BM (2002) Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 84A:1522-1527
16. Qvistgaard E, Kristoffersen H, Terslev L, Danneskiold-Samsoe B, Torp-pedersen S, Bliddal H (2001) Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 9:512-517
17. Migliore A, Tormenta S, Martin LS, Valente C, Massafra U, Granata M, Alimonti A (2004) Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol Dec 9 (Epub ahead of print)
18. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494-502
19. Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24(4):779-781 779-781
20. Sturkenboom MC, Romano F, Simon G, Correa-Leite ML, Villa M, Nicolosi Á., Borgnolo G, White-Porro G, Mannino S (2002) The iatrogenic costs of NSAID therapy: A population study. Arthritis Rheum 47(2):132-140
21. Page J, Henry D (2000) Consumption of NSAIDs and development of congestive heart failure in elderly patients: An underrecognized public health problem. Arch Intern Med 160:777-784
22. Larsen NE, Balazs EA (1991) Drug delivery system using hyaluronan and its derivatives. Adv Drug Deliv Rev 7:279-293
23. Weiss C, Band P (1995) Musculokeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle. Clin Podiatr Med Surg 12:497-517